US Stocks
/
Tempest Therapeutics, Inc. Share Price

Tempest Therapeutics, Inc. Share Price

NASDAQ: TPST | Micro Cap
$0.77
-$0.03 (-3.78%) Last updated on 09 Oct, 2026 | 00:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Tempest Therapeutics, Inc. Stock Performance

Open
$0.77
Prev. Close
$0.80
Circuit Range
N/A
Day Range
$0.77 - $0.78
Year Range
$0.76 - $12.06
Volume
1,912
Average Traded
$0.77

Tempest Therapeutics, Inc. Share Price Today

As of 9 October 2026, Tempest Therapeutics, Inc.'s share price is $0.77. The stock opened at $0.77, compared to its previous close of $0.80. During today's trading session, Tempest Therapeutics, Inc.'s share price traded between $0.77 and $0.78, with an average price of $0.77. Over the past 52 weeks, the stock has recorded a high of $12.06 and a low of $0.76. In terms of performance, Tempest Therapeutics, Inc.'s share price has declined by 61.66% over the last six months and is down 92.57% on a year-on-year basis.

Tempest Therapeutics, Inc. Share Price Chart

$0.77$0.78
L
Show Current Price
H

Tempest Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$3.21M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.40
Revenue (TTM)
$0.00
Return On Equity (TTM)
3713.03%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-49.29%

Tempest Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$3.51-$4.02-$27.70-$5.24
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-14.53%-589.05%81.08%

Tempest Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$35.71-$29.49-$41.84-$26.26
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A17.42%-41.88%37.24%

About Tempest Therapeutics, Inc.

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets. Company's small-molecule product candidate, amezalpat (previously known as TPST-1120), has completed a Phase 2 study in first-line hepatocellular carcinoma and the second small-molecule product candidate is TPST-1495, plans to initiate a Phase 2 study for in familial adenomatous polyposis.

Tempest Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.80
$0.77
-6.52%
Sep 2026
$1.10
$0.83
-24.38%
Aug 2026
$0.88
$1.09
+26.59%
Jul 2026
$1.11
$0.86
-22.42%
Jun 2026
$1.52
$1.11
-27.60%
May 2026
$2.02
$1.54
-23.76%
Apr 2026
$1.65
$2.02
+24.69%
Mar 2026
$2.25
$1.62
-26.36%
Feb 2026
$2.47
$2.20
-19.56%
Jan 2026
$2.87
$2.73
-4.70%
Dec 2025
$3.20
$2.87
-10.31%
Nov 2025
$10.08
$3.20
-69.30%

TPST Share Price FAQs

What is Tempest Therapeutics, Inc. share price today?

chevron-up
Tempest Therapeutics, Inc. share price today is $0.77 as on October 9, 2026 at 12:29 am IST.

What is the 52 week high and 52 week low of Tempest Therapeutics, Inc. stock?

chevron-up
The 52 week high of Tempest Therapeutics, Inc. stock is $12.06, while the 52 week low is $0.76 as of 9 Oct '26.

What is TPST's market capitalisation today?

chevron-up
TPST market capitalisation is $3.21M as of October 9, 2026, at 6:09 pm IST.

What is TPST's net income for the last quarter?

chevron-up
TPST's net income for the last quarter is -5.24B USD.

What is the 5 year returns of TPST?

chevron-up
The 5 year returns of TPST is -99.49% as on 9 Oct '26.

What is the high & low stock price of TPST today?

chevron-up
TPST stock price hit a high of $0.78 and low of $0.77 as of 9 Oct '26.

Can I buy TPST shares in India?

chevron-up
Yes. You can buy TPST in India by opening an international trading account.